NCT03802864 - Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions

Male Infertility

Interventions

DRUG

Liposomal Bupivacaine

After surgical sperm retrieval, the wound will be injected with liposomal bupivacaine (266 mg) mixed with standard bupivacaine (bupivacaine hydrochloride 50mg) for post-operative pain relief.

DRUG

Standard Bupivacaine

After surgical sperm retrieval, the wound will be injected only with standard bupivacaine (bupivacaine hydrochloride 100mg) for post-operative pain relief.

Trial Locations (1)

10065

Weill Cornell Medicine Department of Urology, New York